| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 1.04e-07 | 3 | 95 | 3 | GO:0008184 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 1.04e-06 | 5 | 95 | 3 | GO:0004645 | |
| GeneOntologyMolecularFunction | L-ascorbic acid transmembrane transporter activity | 2.24e-05 | 2 | 95 | 2 | GO:0015229 | |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 2.24e-05 | 2 | 95 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 2.24e-05 | 2 | 95 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | L-ascorbate:sodium symporter activity | 2.24e-05 | 2 | 95 | 2 | GO:0008520 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate phosphatase activity | 2.81e-04 | 27 | 95 | 3 | GO:0034593 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 3.86e-04 | 30 | 95 | 3 | GO:0052866 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 6.11e-04 | 35 | 95 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity | 9.83e-04 | 10 | 95 | 2 | GO:0004439 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate phosphatase activity | 1.43e-03 | 12 | 95 | 2 | GO:0106019 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 5-phosphatase activity | 1.69e-03 | 13 | 95 | 2 | GO:0034595 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.69e-03 | 13 | 95 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 2.10e-03 | 189 | 95 | 5 | GO:0004721 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 2.41e-03 | 56 | 95 | 3 | GO:0030170 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 2.46e-03 | 386 | 95 | 7 | GO:0042578 | |
| GeneOntologyMolecularFunction | phosphatase activity | 2.50e-03 | 287 | 95 | 6 | GO:0016791 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 2.53e-03 | 57 | 95 | 3 | GO:0070279 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 2.57e-03 | 16 | 95 | 2 | GO:0106018 | |
| GeneOntologyBiologicalProcess | glucan catabolic process | 5.95e-07 | 36 | 94 | 5 | GO:0009251 | |
| GeneOntologyBiologicalProcess | polysaccharide catabolic process | 7.87e-07 | 38 | 94 | 5 | GO:0000272 | |
| GeneOntologyBiologicalProcess | glycogen catabolic process | 1.90e-05 | 35 | 94 | 4 | GO:0005980 | |
| GeneOntologyBiologicalProcess | phospholipid biosynthetic process | 3.10e-05 | 268 | 94 | 8 | GO:0008654 | |
| GeneOntologyBiologicalProcess | L-ascorbic acid transmembrane transport | 6.15e-05 | 3 | 94 | 2 | GO:0015882 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | PTGES2 PTPMT1 PIK3C2B OSBPL3 INPP5E FDPS CYP11B1 CYP11B2 PI4KB MTM1 GPAM HMGCS2 ABCD2 | 7.95e-05 | 813 | 94 | 13 | GO:0008610 |
| GeneOntologyBiologicalProcess | glucan metabolic process | 9.90e-05 | 101 | 94 | 5 | GO:0044042 | |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | 1.06e-04 | 410 | 94 | 9 | GO:0006644 | |
| GeneOntologyBiologicalProcess | farnesyl diphosphate biosynthetic process | 1.23e-04 | 4 | 94 | 2 | GO:0045337 | |
| GeneOntologyBiologicalProcess | regulation of blood volume by renal aldosterone | 1.23e-04 | 4 | 94 | 2 | GO:0002017 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol metabolic process | 1.28e-04 | 170 | 94 | 6 | GO:0046488 | |
| GeneOntologyBiologicalProcess | polysaccharide metabolic process | 2.79e-04 | 126 | 94 | 5 | GO:0005976 | |
| GeneOntologyBiologicalProcess | farnesyl diphosphate metabolic process | 3.05e-04 | 6 | 94 | 2 | GO:0045338 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol dephosphorylation | 3.40e-04 | 30 | 94 | 3 | GO:0046856 | |
| MousePheno | abnormal adrenocortical cell morphology | 1.47e-05 | 10 | 71 | 3 | MP:0008291 | |
| MousePheno | abnormal urine progesterone level | 2.54e-05 | 2 | 71 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 2.54e-05 | 2 | 71 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 2.54e-05 | 2 | 71 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 2.54e-05 | 2 | 71 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 2.54e-05 | 2 | 71 | 2 | MP:0011546 | |
| MousePheno | increased variability of skeletal muscle fiber size | 6.49e-05 | 43 | 71 | 4 | MP:0009403 | |
| MousePheno | abnormal skeletal muscle fiber size | 7.61e-05 | 140 | 71 | 6 | MP:0009398 | |
| MousePheno | muscle weakness | 1.38e-04 | 98 | 71 | 5 | MP:0000747 | |
| MousePheno | abnormal adrenal gland zona glomerulosa morphology | 1.52e-04 | 4 | 71 | 2 | MP:0008293 | |
| MousePheno | decreased urine aldosterone level | 1.52e-04 | 4 | 71 | 2 | MP:0011541 | |
| MousePheno | abnormal urine aldosterone level | 1.52e-04 | 4 | 71 | 2 | MP:0011539 | |
| MousePheno | abnormal urine corticosterone level | 1.52e-04 | 4 | 71 | 2 | MP:0011548 | |
| MousePheno | decreased urine hormone level | 1.52e-04 | 4 | 71 | 2 | MP:0014459 | |
| MousePheno | abnormal circulating ketone body level | 1.60e-04 | 54 | 71 | 4 | MP:0003457 | |
| MousePheno | abnormal physical strength | CACNA1A SLC6A8 SNX14 PTPRA SBF1 ADAMTSL5 MTM1 CNTNAP1 FSD2 WSB2 SMARCD3 PYGM NEB CSMD3 EFTUD2 | 1.63e-04 | 1027 | 71 | 15 | MP:0004262 |
| MousePheno | abnormal spine curvature | 2.01e-04 | 318 | 71 | 8 | MP:0004174 | |
| MousePheno | abnormal muscle fiber morphology | 2.04e-04 | 406 | 71 | 9 | MP:0004087 | |
| MousePheno | abnormal grip strength | CACNA1A SLC6A8 SNX14 PTPRA SBF1 ADAMTSL5 MTM1 FSD2 WSB2 SMARCD3 PYGM NEB CSMD3 EFTUD2 | 2.45e-04 | 946 | 71 | 14 | MP:0001515 |
| MousePheno | increased adrenal gland zona fasciculata size | 2.52e-04 | 5 | 71 | 2 | MP:0014286 | |
| MousePheno | abnormal node of Ranvier morphology | 2.52e-04 | 5 | 71 | 2 | MP:0010732 | |
| MousePheno | enlarged floor plate | 2.52e-04 | 5 | 71 | 2 | MP:0012675 | |
| MousePheno | uterus adenomyosis | 3.77e-04 | 6 | 71 | 2 | MP:0009221 | |
| MousePheno | abnormal paranode morphology | 3.77e-04 | 6 | 71 | 2 | MP:0010734 | |
| MousePheno | increased urine hormone level | 3.77e-04 | 6 | 71 | 2 | MP:0014458 | |
| MousePheno | adrenal gland hyperplasia | 3.77e-04 | 6 | 71 | 2 | MP:0009078 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | CACNA1A HSPG2 SBF1 INPP5E CYP11B1 CYP11B2 MTM1 SH2D3C DVL2 FES HMGCS2 ARRDC3 NEB SLC23A1 EFTUD2 | 4.34e-04 | 1124 | 71 | 15 | MP:0011112 |
| MousePheno | abnormal urine hormone level | 5.25e-04 | 7 | 71 | 2 | MP:0011538 | |
| MousePheno | abnormal vitamin C level | 5.25e-04 | 7 | 71 | 2 | MP:0011229 | |
| MousePheno | pituitary gland hyperplasia | 5.25e-04 | 7 | 71 | 2 | MP:0000635 | |
| MousePheno | abnormal muscle electrophysiology | 5.60e-04 | 32 | 71 | 3 | MP:0004145 | |
| MousePheno | increased circulating angiotensin II level | 6.98e-04 | 8 | 71 | 2 | MP:0031232 | |
| MousePheno | increased angiotensin II level | 6.98e-04 | 8 | 71 | 2 | MP:0031229 | |
| MousePheno | abnormal skeletal muscle fiber morphology | 7.15e-04 | 212 | 71 | 6 | MP:0003084 | |
| MousePheno | internal hemorrhage | 7.45e-04 | 387 | 71 | 8 | MP:0001634 | |
| MousePheno | abnormal forebrain morphology | SLC6A8 USP18 HSPG2 PTPRA TMEM94 INPP5E CYP11B1 CYP11B2 SH2D3C FES CUL9 MAGEE2 PARD3 CSMD3 | 8.62e-04 | 1072 | 71 | 14 | MP:0000783 |
| MousePheno | postaxial polydactyly | 8.95e-04 | 9 | 71 | 2 | MP:0009744 | |
| MousePheno | increased brain size | 9.07e-04 | 85 | 71 | 4 | MP:0005238 | |
| MousePheno | increased circulating ketone body level | 1.01e-03 | 39 | 71 | 3 | MP:0002575 | |
| MousePheno | kyphosis | 1.07e-03 | 229 | 71 | 6 | MP:0000160 | |
| MousePheno | abnormal Z line morphology | 1.08e-03 | 40 | 71 | 3 | MP:0004091 | |
| MousePheno | decreased circulating renin level | 1.11e-03 | 10 | 71 | 2 | MP:0003353 | |
| MousePheno | abnormal A band morphology | 1.11e-03 | 10 | 71 | 2 | MP:0030566 | |
| MousePheno | abnormal muscle morphology | SLC6A8 HSPG2 NEURL2 RTEL1 TMEM94 CYP11B1 CYP11B2 MTM1 OBSCN FES SMARCD3 PYGM NEB IRX4 | 1.17e-03 | 1106 | 71 | 14 | MP:0002108 |
| MousePheno | abnormal I band morphology | 1.25e-03 | 42 | 71 | 3 | MP:0030567 | |
| MousePheno | abnormal adrenal cortex morphology | 1.25e-03 | 42 | 71 | 3 | MP:0008288 | |
| MousePheno | decreased circulating insulin level | 1.30e-03 | 238 | 71 | 6 | MP:0002727 | |
| MousePheno | ketosis | 1.34e-03 | 43 | 71 | 3 | MP:0030970 | |
| MousePheno | decreased circulating corticosterone level | 1.34e-03 | 43 | 71 | 3 | MP:0002665 | |
| MousePheno | abnormal adrenal gland zona fasciculata size | 1.36e-03 | 11 | 71 | 2 | MP:0014284 | |
| MousePheno | uterus cyst | 1.36e-03 | 11 | 71 | 2 | MP:0009082 | |
| MousePheno | decreased circulating glucocorticoid level | 1.43e-03 | 44 | 71 | 3 | MP:0003368 | |
| MousePheno | perinatal lethality | CACNA1A HSPG2 FAT4 TMEM94 INPP5E MTM1 SH2D3C DVL2 ARRDC3 CUL7 SLC23A2 SLC23A1 PTK7 EFTUD2 | 1.44e-03 | 1130 | 71 | 14 | MP:0002081 |
| MousePheno | abnormal circulating angiotensin II level | 1.62e-03 | 12 | 71 | 2 | MP:0031230 | |
| MousePheno | abnormal angiotensin II level | 1.62e-03 | 12 | 71 | 2 | MP:0031227 | |
| MousePheno | hypokalemia | 1.62e-03 | 12 | 71 | 2 | MP:0004119 | |
| MousePheno | enlarged pituitary gland | 1.62e-03 | 12 | 71 | 2 | MP:0000636 | |
| MousePheno | lethality at weaning, complete penetrance | 1.63e-03 | 46 | 71 | 3 | MP:0011083 | |
| Domain | PHOSPHORYLASE | 1.27e-07 | 3 | 95 | 3 | PS00102 | |
| Domain | Phosphorylase | 1.27e-07 | 3 | 95 | 3 | PF00343 | |
| Domain | Glycg_phsphrylas | 1.27e-07 | 3 | 95 | 3 | IPR011833 | |
| Domain | Glyco_trans_35 | 1.27e-07 | 3 | 95 | 3 | IPR000811 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.13e-05 | 99 | 95 | 6 | IPR029021 | |
| Domain | Cyt_P450_mitochondrial | 2.56e-05 | 2 | 95 | 2 | IPR002399 | |
| Domain | Myotubularin-like_Pase_dom | 4.46e-05 | 14 | 95 | 3 | IPR010569 | |
| Domain | PPASE_MYOTUBULARIN | 4.46e-05 | 14 | 95 | 3 | PS51339 | |
| Domain | Myotubularin_fam | 4.46e-05 | 14 | 95 | 3 | IPR030564 | |
| Domain | Myotub-related | 4.46e-05 | 14 | 95 | 3 | PF06602 | |
| Domain | GRAM | 6.80e-05 | 16 | 95 | 3 | SM00568 | |
| Domain | Cul7 | 7.65e-05 | 3 | 95 | 2 | PF11515 | |
| Domain | Xan_ur_permease | 7.65e-05 | 3 | 95 | 2 | PF00860 | |
| Domain | Xant/urac/vitC | 7.65e-05 | 3 | 95 | 2 | IPR006043 | |
| Domain | CPH_domain | 7.65e-05 | 3 | 95 | 2 | IPR021097 | |
| Domain | TYR_PHOSPHATASE_dom | 8.14e-05 | 87 | 95 | 5 | IPR000387 | |
| Domain | ConA-like_dom | 1.28e-04 | 219 | 95 | 7 | IPR013320 | |
| Domain | GRAM | 1.83e-04 | 22 | 95 | 3 | PF02893 | |
| Domain | GRAM | 1.83e-04 | 22 | 95 | 3 | IPR004182 | |
| Domain | Tyr_Pase_AS | 5.23e-04 | 73 | 95 | 4 | IPR016130 | |
| Domain | APC_su10/DOC_dom | 5.29e-04 | 7 | 95 | 2 | IPR004939 | |
| Domain | DOC | 5.29e-04 | 7 | 95 | 2 | PS51284 | |
| Domain | APC10 | 5.29e-04 | 7 | 95 | 2 | SM01337 | |
| Domain | ANAPC10 | 5.29e-04 | 7 | 95 | 2 | PF03256 | |
| Domain | Cullin_Nedd8 | 7.03e-04 | 8 | 95 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 7.03e-04 | 8 | 95 | 2 | SM00884 | |
| Domain | Cullin_neddylation_domain | 7.03e-04 | 8 | 95 | 2 | IPR019559 | |
| Domain | Cullin_homology | 9.00e-04 | 9 | 95 | 2 | IPR016158 | |
| Domain | LAM_G_DOMAIN | 9.45e-04 | 38 | 95 | 3 | PS50025 | |
| Domain | TYR_PHOSPHATASE_1 | 9.70e-04 | 86 | 95 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 1.01e-03 | 87 | 95 | 4 | PS50056 | |
| Domain | Laminin_G_2 | 1.10e-03 | 40 | 95 | 3 | PF02210 | |
| Domain | Cullin | 1.12e-03 | 10 | 95 | 2 | PF00888 | |
| Domain | CULLIN_2 | 1.12e-03 | 10 | 95 | 2 | PS50069 | |
| Domain | Rap_GAP | 1.12e-03 | 10 | 95 | 2 | PF02145 | |
| Domain | PIK_HELICAL | 1.12e-03 | 10 | 95 | 2 | PS51545 | |
| Domain | PI_Kinase | 1.12e-03 | 10 | 95 | 2 | IPR015433 | |
| Domain | Cullin_N | 1.12e-03 | 10 | 95 | 2 | IPR001373 | |
| Domain | PInositide-3_kin_accessory_dom | 1.12e-03 | 10 | 95 | 2 | IPR001263 | |
| Domain | CULLIN_1 | 1.12e-03 | 10 | 95 | 2 | PS01256 | |
| Domain | - | 1.25e-03 | 92 | 95 | 4 | 3.90.190.10 | |
| Domain | Rap_GAP_dom | 1.37e-03 | 11 | 95 | 2 | IPR000331 | |
| Domain | RAPGAP | 1.37e-03 | 11 | 95 | 2 | PS50085 | |
| Domain | ZnF_BED | 1.37e-03 | 11 | 95 | 2 | SM00614 | |
| Domain | - | 1.40e-03 | 95 | 95 | 4 | 2.60.120.200 | |
| Domain | LamG | 1.45e-03 | 44 | 95 | 3 | SM00282 | |
| Domain | Znf_BED | 1.63e-03 | 12 | 95 | 2 | IPR003656 | |
| Domain | KRAB | 2.34e-03 | 358 | 95 | 7 | PS50805 | |
| Domain | KRAB | 2.34e-03 | 358 | 95 | 7 | PF01352 | |
| Domain | PI3/4_kinase_CS | 2.57e-03 | 15 | 95 | 2 | IPR018936 | |
| Domain | KRAB | 2.77e-03 | 369 | 95 | 7 | SM00349 | |
| Domain | KRAB | 2.81e-03 | 370 | 95 | 7 | IPR001909 | |
| Domain | - | 2.93e-03 | 16 | 95 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.93e-03 | 16 | 95 | 2 | SM00146 | |
| Domain | Laminin_G | 3.21e-03 | 58 | 95 | 3 | IPR001791 | |
| Domain | PTPc_motif | 3.37e-03 | 59 | 95 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.37e-03 | 59 | 95 | 3 | IPR003595 | |
| Domain | Rib_L2_dom2 | 3.71e-03 | 18 | 95 | 2 | IPR014722 | |
| Domain | PI3/4_kinase_cat_dom | 3.71e-03 | 18 | 95 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 3.71e-03 | 18 | 95 | 2 | PF00454 | |
| Domain | - | 3.71e-03 | 18 | 95 | 2 | 2.30.30.30 | |
| Domain | PI3_4_KINASE_3 | 3.71e-03 | 18 | 95 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 3.71e-03 | 18 | 95 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.71e-03 | 18 | 95 | 2 | PS00916 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | PTGES2 SBF1 PIK3C2B OSBPL3 INPP5E FDPS CYP11B1 CYP11B2 PI4KB MTM1 SMARCD3 GPAM HMGCS2 MTMR9 | 9.88e-07 | 620 | 67 | 14 | MM15193 |
| Pathway | REACTOME_PI_METABOLISM | 1.67e-06 | 77 | 67 | 6 | MM14590 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | PTGES2 PTPMT1 SBF1 PIK3C2B OSBPL3 INPP5E FDPS CYP11B1 CYP11B2 PI4KB MTM1 SMARCD3 GPAM HMGCS2 MTMR9 | 1.96e-06 | 757 | 67 | 15 | M27451 |
| Pathway | REACTOME_PI_METABOLISM | 2.79e-06 | 84 | 67 | 6 | M676 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 6.74e-06 | 211 | 67 | 8 | M649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION | 8.45e-06 | 9 | 67 | 3 | M47621 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 3.60e-05 | 14 | 67 | 3 | M19193 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 3.88e-05 | 196 | 67 | 7 | MM14591 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 6.54e-05 | 46 | 67 | 4 | M48317 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 8.41e-05 | 49 | 67 | 4 | M40046 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 8.88e-05 | 154 | 67 | 6 | M27832 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.06e-04 | 52 | 67 | 4 | M14171 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES | 1.81e-04 | 111 | 67 | 5 | M48065 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 2.19e-04 | 25 | 67 | 3 | M27857 | |
| Pathway | KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE | 2.20e-04 | 5 | 67 | 2 | M47522 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 5.53e-04 | 34 | 67 | 3 | MM15985 | |
| Pathway | REACTOME_VITAMIN_C_ASCORBATE_METABOLISM | 6.12e-04 | 8 | 67 | 2 | M27091 | |
| Pathway | BIOCARTA_FEEDER_PATHWAY | 7.84e-04 | 9 | 67 | 2 | M3061 | |
| Pathway | REACTOME_VITAMIN_C_ASCORBATE_METABOLISM | 7.84e-04 | 9 | 67 | 2 | MM14769 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 8.94e-04 | 40 | 67 | 3 | M39595 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 9.77e-04 | 10 | 67 | 2 | M27076 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 1.03e-03 | 42 | 67 | 3 | M27172 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.19e-03 | 11 | 67 | 2 | M15422 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 1.19e-03 | 11 | 67 | 2 | MM14750 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | 1.19e-03 | 11 | 67 | 2 | M655 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.42e-03 | 12 | 67 | 2 | MM1526 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEVALONATE_PATHWAY | 1.42e-03 | 12 | 67 | 2 | M47946 | |
| Pathway | REACTOME_MINERALOCORTICOID_BIOSYNTHESIS | 1.42e-03 | 12 | 67 | 2 | MM14749 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 1.71e-03 | 50 | 67 | 3 | MM14641 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 1.95e-03 | 14 | 67 | 2 | MM15391 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 1.95e-03 | 14 | 67 | 2 | M46449 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 1.95e-03 | 14 | 67 | 2 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 2.03e-03 | 53 | 67 | 3 | M662 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 2.14e-03 | 54 | 67 | 3 | M3896 | |
| Pathway | KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS | 2.25e-03 | 15 | 67 | 2 | M13465 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 2.26e-03 | 55 | 67 | 3 | M27001 | |
| Pathway | WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM | 2.56e-03 | 16 | 67 | 2 | M39815 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LRRC8E SLC6A8 HSPG2 SBF1 ADAMTSL5 PIK3C2B TMEM94 INPP5E MCM3AP KSR2 OBSCN CUL9 PYGB WDR90 ANKLE1 | 3.17e-07 | 1105 | 95 | 15 | 35748872 |
| Pubmed | Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human. | 2.34e-06 | 10 | 95 | 3 | 9736772 | |
| Pubmed | 2.58e-06 | 141 | 95 | 6 | 18636124 | ||
| Pubmed | A compendium of expression patterns of cholesterol biosynthetic enzymes in the mouse embryo. | 3.22e-06 | 37 | 95 | 4 | 26108225 | |
| Pubmed | 7.03e-06 | 14 | 95 | 3 | 22653443 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17651452 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23150505 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34743356 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 7.38e-06 | 2 | 95 | 2 | 21164264 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 2783417 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 19216494 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 18845575 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22348976 | ||
| Pubmed | Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. | 7.38e-06 | 2 | 95 | 2 | 2256920 | |
| Pubmed | Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism. | 7.38e-06 | 2 | 95 | 2 | 20339375 | |
| Pubmed | Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. | 7.38e-06 | 2 | 95 | 2 | 15699546 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 18162527 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 38341019 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 10556521 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 20708777 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 19243932 | ||
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 7.38e-06 | 2 | 95 | 2 | 22217843 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34599650 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 20808686 | ||
| Pubmed | Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. | 7.38e-06 | 2 | 95 | 2 | 16396990 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24837548 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 8645611 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 30046010 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17664139 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 10395795 | ||
| Pubmed | Familial and phenotypic associations of the aldosterone Renin ratio. | 7.38e-06 | 2 | 95 | 2 | 19820005 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 10471399 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 21733302 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23837633 | ||
| Pubmed | N-Glycosylation is required for Na+-dependent vitamin C transporter functionality. | 7.38e-06 | 2 | 95 | 2 | 18619416 | |
| Pubmed | Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. | 7.38e-06 | 2 | 95 | 2 | 15993839 | |
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 7.38e-06 | 2 | 95 | 2 | 18397978 | |
| Pubmed | Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain. | 7.38e-06 | 2 | 95 | 2 | 12231255 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 18791929 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 1518866 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 20634641 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 28177761 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23613229 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 1303253 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 16357110 | ||
| Pubmed | Vitamin C transporter gene polymorphisms, dietary vitamin C and serum ascorbic acid. | 7.38e-06 | 2 | 95 | 2 | 20588054 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22622494 | ||
| Pubmed | Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. | 7.38e-06 | 2 | 95 | 2 | 21519965 | |
| Pubmed | Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. | 7.38e-06 | 2 | 95 | 2 | 21625068 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24815519 | ||
| Pubmed | Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production. | 7.38e-06 | 2 | 95 | 2 | 15062555 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 18247577 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 16110193 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23761669 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26066897 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 25130497 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 18417304 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17075030 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17075029 | ||
| Pubmed | Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). | 7.38e-06 | 2 | 95 | 2 | 2592361 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 20471816 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 27932501 | ||
| Pubmed | Gender and sodium-ascorbate transporter isoforms determine ascorbate concentrations in mice. | 7.38e-06 | 2 | 95 | 2 | 15333707 | |
| Pubmed | CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. | 7.38e-06 | 2 | 95 | 2 | 15507509 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11984580 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 10631088 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11984597 | ||
| Pubmed | Polymorphism of CYP11B2 determines salt sensitivity in Japanese. | 7.38e-06 | 2 | 95 | 2 | 17296872 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23314847 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17980006 | ||
| Pubmed | Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene. | 7.38e-06 | 2 | 95 | 2 | 16984984 | |
| Pubmed | Evidence for local aldosterone synthesis in the large intestine of the mouse. | 7.38e-06 | 2 | 95 | 2 | 35288482 | |
| Pubmed | Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. | 7.38e-06 | 2 | 95 | 2 | 15731365 | |
| Pubmed | Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. | 7.38e-06 | 2 | 95 | 2 | 18039983 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34780525 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 1741400 | ||
| Pubmed | Cyp11b1 null mouse, a model of congenital adrenal hyperplasia. | 7.38e-06 | 2 | 95 | 2 | 19029289 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 32540969 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 9804989 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26047574 | ||
| Pubmed | A family of mammalian Na+-dependent L-ascorbic acid transporters. | 7.38e-06 | 2 | 95 | 2 | 10331392 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26324851 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11396616 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 18651133 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 36310070 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 7669222 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22083159 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 15522937 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22933298 | ||
| Pubmed | 8.77e-06 | 15 | 95 | 3 | 2575583 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | C5orf22 PTPRA PTPMT1 SBF1 OSBPL3 MTM1 GRAMD1A PYGL TTC17 PTPN21 ZNF548 PTK7 | 1.41e-05 | 974 | 95 | 12 | 28675297 |
| Pubmed | NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling. | 2.21e-05 | 3 | 95 | 2 | 22081014 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 36861295 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 20122894 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 21467193 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 36778748 | ||
| Pubmed | Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. | 2.21e-05 | 3 | 95 | 2 | 8111631 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 34673103 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 2546938 | ||
| GeneFamily | Glycogen phosphorylases | 6.06e-08 | 3 | 72 | 3 | 437 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 2.66e-05 | 15 | 72 | 3 | 903 | |
| GeneFamily | Cytochrome P450 family 11 | 4.68e-05 | 3 | 72 | 2 | 1007 | |
| GeneFamily | Phosphoinositide phosphatases | 2.76e-04 | 32 | 72 | 3 | 1079 | |
| GeneFamily | Cullins | 4.31e-04 | 8 | 72 | 2 | 1032 | |
| GeneFamily | Cadherin related | 2.05e-03 | 17 | 72 | 2 | 24 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF132 ZNF773 ZNF334 ZNF658 ZNF415 ZNF548 ZNF653 ZNF181 ZNF304 | 2.12e-03 | 718 | 72 | 9 | 28 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-08 | 146 | 95 | 7 | 86cddd0e7f954547b7ffdccb0329cd5c4b725ac1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-06 | 168 | 95 | 6 | 0f736d58cb0ff042fa3ce58e36bde37b6976f8fc | |
| Drug | heptenitol | 9.44e-09 | 7 | 94 | 4 | CID000188267 | |
| Drug | 3,5-dimethylphenyl isocyanate | 6.82e-08 | 3 | 94 | 3 | CID000521488 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 6.82e-08 | 3 | 94 | 3 | CID000147839 | |
| Drug | NSC758405 | 6.82e-08 | 3 | 94 | 3 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 6.82e-08 | 3 | 94 | 3 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 6.82e-08 | 3 | 94 | 3 | CID000196007 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 6.82e-08 | 3 | 94 | 3 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 6.82e-08 | 3 | 94 | 3 | CID000191554 | |
| Drug | hydan | 6.82e-08 | 3 | 94 | 3 | CID000008360 | |
| Drug | EHMF | 6.82e-08 | 3 | 94 | 3 | CID000033931 | |
| Drug | pyridoxal 5'-methylenephosphonate | 6.82e-08 | 3 | 94 | 3 | CID003082249 | |
| Drug | Plp 5'-mpa | 6.82e-08 | 3 | 94 | 3 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 6.82e-08 | 3 | 94 | 3 | CID000191723 | |
| Drug | 3'-FFdUrd | 6.82e-08 | 3 | 94 | 3 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 6.82e-08 | 3 | 94 | 3 | CID000119518 | |
| Drug | AC1L8XK3 | 6.82e-08 | 3 | 94 | 3 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 6.82e-08 | 3 | 94 | 3 | CID000446801 | |
| Drug | riboflavin tetraacetate | 6.82e-08 | 3 | 94 | 3 | CID000094186 | |
| Drug | 2,5-dimethyl-3-furanone | 6.82e-08 | 3 | 94 | 3 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 6.82e-08 | 3 | 94 | 3 | CID000011459 | |
| Drug | glucosyl fluoride | 8.79e-08 | 11 | 94 | 4 | CID000150967 | |
| Drug | 9 Da | 8.79e-08 | 11 | 94 | 4 | CID005287565 | |
| Drug | galocitabine | 2.72e-07 | 4 | 94 | 3 | CID000065950 | |
| Drug | 5-deoxyribose-1-phosphate | 2.72e-07 | 4 | 94 | 3 | CID000135786 | |
| Drug | ingliforib | 2.72e-07 | 4 | 94 | 3 | CID006451325 | |
| Drug | uric acid riboside | 2.72e-07 | 4 | 94 | 3 | CID000164933 | |
| Drug | pseudo-dl-glucose | 2.72e-07 | 4 | 94 | 3 | CID000125259 | |
| Drug | pyridoxal diphosphate | 2.72e-07 | 4 | 94 | 3 | CID000125696 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 2.72e-07 | 4 | 94 | 3 | CID000189134 | |
| Drug | AC1LAMW2 | 2.72e-07 | 4 | 94 | 3 | CID000491364 | |
| Drug | FdUrd-C8 | 2.72e-07 | 4 | 94 | 3 | CID000094262 | |
| Drug | Mem-CC | 2.72e-07 | 4 | 94 | 3 | CID003081269 | |
| Drug | BCIp4A | 2.72e-07 | 4 | 94 | 3 | CID000192417 | |
| Drug | 3'-chloromethotrexate | 2.72e-07 | 4 | 94 | 3 | CID000097703 | |
| Drug | 4-nitrophenylmaltoheptaoside | 3.59e-07 | 15 | 94 | 4 | CID000173254 | |
| Drug | butylethanolamine | 4.77e-07 | 16 | 94 | 4 | CID000249006 | |
| Drug | homonojirimycin | 6.22e-07 | 17 | 94 | 4 | CID000159496 | |
| Drug | fagomine | 6.22e-07 | 17 | 94 | 4 | CID000072259 | |
| Drug | heptulose-2-P | 6.77e-07 | 5 | 94 | 3 | CID000124823 | |
| Drug | 6-FPLP | 6.77e-07 | 5 | 94 | 3 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 6.77e-07 | 5 | 94 | 3 | CID009576855 | |
| Drug | DHPBU | 6.77e-07 | 5 | 94 | 3 | CID000125914 | |
| Drug | 5'-isobutylthioinosine | 6.77e-07 | 5 | 94 | 3 | CID003080910 | |
| Drug | indirubin-5-sulphonate | 6.77e-07 | 5 | 94 | 3 | CID005288641 | |
| Drug | AC1LCUXJ | 6.77e-07 | 5 | 94 | 3 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 6.77e-07 | 5 | 94 | 3 | CID000080578 | |
| Drug | etafenone | 6.77e-07 | 5 | 94 | 3 | CID000003275 | |
| Drug | ddEtUrd | 6.77e-07 | 5 | 94 | 3 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 6.77e-07 | 5 | 94 | 3 | CID000125618 | |
| Drug | m-anisidine | 6.77e-07 | 5 | 94 | 3 | CID000010824 | |
| Drug | 2-hydroxypropylphosphonate | 6.77e-07 | 5 | 94 | 3 | CID000441028 | |
| Drug | 6-FDPL | 6.77e-07 | 5 | 94 | 3 | CID000129578 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 6.77e-07 | 5 | 94 | 3 | CID003082179 | |
| Drug | GlcMan | 6.77e-07 | 5 | 94 | 3 | CID000152120 | |
| Drug | U66985 | 6.77e-07 | 5 | 94 | 3 | CID000127224 | |
| Drug | AC1O3M08 | 6.77e-07 | 5 | 94 | 3 | CID006331955 | |
| Drug | CV-araU | 1.35e-06 | 6 | 94 | 3 | CID006441877 | |
| Drug | 2-thiothymidine | 1.35e-06 | 6 | 94 | 3 | CID003005944 | |
| Drug | Carbocyclic Bvdc | 1.35e-06 | 6 | 94 | 3 | CID006438602 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 1.35e-06 | 6 | 94 | 3 | CID000152984 | |
| Drug | EdUMP | 1.35e-06 | 6 | 94 | 3 | CID003085112 | |
| Drug | 5'-deoxy-5'-chloroformycin | 1.35e-06 | 6 | 94 | 3 | CID000126430 | |
| Drug | 5-n-propylthioadenosine | 1.35e-06 | 6 | 94 | 3 | CID000656428 | |
| Drug | AzddCyd | 1.35e-06 | 6 | 94 | 3 | CID000451374 | |
| Drug | 5-Ffdru | 1.35e-06 | 6 | 94 | 3 | CID000065561 | |
| Drug | Carbocyclic Ivdu | 1.35e-06 | 6 | 94 | 3 | CID006439191 | |
| Drug | DNPP | 1.35e-06 | 6 | 94 | 3 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 1.35e-06 | 6 | 94 | 3 | CID000082693 | |
| Drug | NSC-97433 | 1.35e-06 | 6 | 94 | 3 | CID000001803 | |
| Drug | AR-L57 | 1.35e-06 | 6 | 94 | 3 | CID000156890 | |
| Drug | AC1L3XPY | 1.55e-06 | 21 | 94 | 4 | CID000124005 | |
| Drug | I0329 | 1.55e-06 | 21 | 94 | 4 | CID000439668 | |
| Drug | maltosaccharide | 1.88e-06 | 22 | 94 | 4 | CID005461034 | |
| Drug | ginsenoside | 2.27e-06 | 23 | 94 | 4 | CID000092797 | |
| Drug | alpha-(fluoromethyl)dehydroornithine | 2.36e-06 | 7 | 94 | 3 | CID006439607 | |
| Drug | 6-fluoropyridoxal | 2.36e-06 | 7 | 94 | 3 | CID003080803 | |
| Drug | AC1L3372 | 2.36e-06 | 7 | 94 | 3 | CID000108025 | |
| Drug | 1 Gpt | 2.36e-06 | 7 | 94 | 3 | CID000101247 | |
| Drug | formycins | 2.36e-06 | 7 | 94 | 3 | CID000512867 | |
| Drug | 5'-methylthioinosine | 2.36e-06 | 7 | 94 | 3 | CID000161214 | |
| Drug | hydantocidin | 2.36e-06 | 7 | 94 | 3 | CID000125429 | |
| Drug | 2',3'-dideoxy-3'-fluorocytidine | 2.36e-06 | 7 | 94 | 3 | CID000356019 | |
| Drug | Promonta | 2.36e-06 | 7 | 94 | 3 | CID000108494 | |
| Drug | 1,2-dideoxy-d-arabino-hex-1-enopyranose | 3.22e-06 | 25 | 94 | 4 | CID000089465 | |
| Drug | 6-methylpurine | 3.76e-06 | 8 | 94 | 3 | CID005287547 | |
| Drug | Etafenone [inn] | 3.76e-06 | 8 | 94 | 3 | CID000066659 | |
| Drug | AC1NUVX5 | 3.76e-06 | 8 | 94 | 3 | CID005461894 | |
| Drug | amorphin | 3.76e-06 | 8 | 94 | 3 | CID000122792 | |
| Drug | LB-2 | 5.17e-06 | 28 | 94 | 4 | CID000129887 | |
| Drug | alpha-maltosyl fluoride | 5.62e-06 | 9 | 94 | 3 | CID000194237 | |
| Drug | 6-benzyl-2-thiouracil | 5.62e-06 | 9 | 94 | 3 | CID000685814 | |
| Drug | 5'-methylthiotubercidin | 5.62e-06 | 9 | 94 | 3 | CID000188350 | |
| Drug | 5-Iodoribose 1-phosphate | 5.62e-06 | 9 | 94 | 3 | CID003035973 | |
| Drug | 5'-iodo-5'-deoxyadenosine | 5.62e-06 | 9 | 94 | 3 | CID000107502 | |
| Drug | 8-azidoadenosine 5'-monophosphate | 8.01e-06 | 10 | 94 | 3 | CID000124726 | |
| Drug | 6-methyluridine | 8.01e-06 | 10 | 94 | 3 | CID000092887 | |
| Drug | UDP-pyridoxal | 8.01e-06 | 10 | 94 | 3 | CID000126789 | |
| Drug | 2,6-dihydroxypyridine | 8.01e-06 | 10 | 94 | 3 | CID000069371 | |
| Drug | Cid 11299980 | 1.10e-05 | 11 | 94 | 3 | CID009856533 | |
| Drug | AC1L6KTW | 1.39e-05 | 74 | 94 | 5 | CID000247705 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 8.79e-06 | 2 | 88 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | Glucocorticoid-remediable aldosteronism | 8.79e-06 | 2 | 88 | 2 | C1260386 | |
| Disease | X-24431 measurement | 2.63e-05 | 3 | 88 | 2 | EFO_0800882 | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 2.63e-05 | 3 | 88 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | dextro-looped transposition of the great arteries (implicated_via_orthology) | 5.26e-05 | 4 | 88 | 2 | DOID:0060770 (implicated_via_orthology) | |
| Disease | tartronate (hydroxymalonate) measurement | 5.26e-05 | 4 | 88 | 2 | EFO_0800944 | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 8.74e-05 | 5 | 88 | 2 | DOID:446 (is_implicated_in) | |
| Disease | right ventricular ejection fraction measurement | 9.82e-05 | 30 | 88 | 3 | EFO_0021816 | |
| Disease | Conn Syndrome | 1.31e-04 | 6 | 88 | 2 | C1384514 | |
| Disease | extraversion measurement | 1.31e-04 | 6 | 88 | 2 | EFO_0007913 | |
| Disease | Hyperaldosteronism | 1.31e-04 | 6 | 88 | 2 | C0020428 | |
| Disease | centronuclear myopathy (implicated_via_orthology) | 1.83e-04 | 7 | 88 | 2 | DOID:14717 (implicated_via_orthology) | |
| Disease | protocadherin alpha-7 measurement | 1.83e-04 | 7 | 88 | 2 | EFO_0801973 | |
| Disease | Charcot-Marie-Tooth disease | 2.70e-04 | 42 | 88 | 3 | cv:C0007959 | |
| Disease | suicide behaviour measurement | 2.90e-04 | 43 | 88 | 3 | EFO_0006882 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 3.12e-04 | 9 | 88 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | protein FAM163B measurement | 3.12e-04 | 9 | 88 | 2 | EFO_0802936 | |
| Disease | threonate measurement | 3.90e-04 | 10 | 88 | 2 | EFO_0021032 | |
| Disease | androstenedione measurement | 3.90e-04 | 10 | 88 | 2 | EFO_0007972 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 4.75e-04 | 11 | 88 | 2 | EFO_0021862 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 4.75e-04 | 11 | 88 | 2 | EFO_0801461 | |
| Disease | sleep duration | 7.61e-04 | 362 | 88 | 6 | EFO_0005271 | |
| Disease | ascorbic acid 3-sulfate measurement | 7.82e-04 | 14 | 88 | 2 | EFO_0800173 | |
| Disease | glycerate measurement | 9.00e-04 | 15 | 88 | 2 | EFO_0021029 | |
| Disease | vitamin C measurement | 1.03e-03 | 16 | 88 | 2 | EFO_0600003 | |
| Disease | visceral adipose tissue measurement, body mass index | 2.27e-03 | 87 | 88 | 3 | EFO_0004340, EFO_0004765 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.33e-03 | 24 | 88 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | apolipoprotein L1 measurement | 2.52e-03 | 25 | 88 | 2 | EFO_0021854 | |
| Disease | age-related hearing impairment | 2.88e-03 | 324 | 88 | 5 | EFO_0005782 | |
| Disease | Glycogen Storage Disease | 2.94e-03 | 27 | 88 | 2 | C0017919 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SILGPHHLDEYVRVW | 1821 | O00555 | |
| GVLNDQHWHYVRVDR | 256 | P78357 | |
| TRARPYVHLWEALGH | 491 | Q8NAG6 | |
| ILEHGRWRIVNGSHY | 2701 | Q7Z407 | |
| NVHLYHIVQREGGWD | 586 | Q9UBJ2 | |
| SEDLRSHAWYHGRIP | 146 | O75815 | |
| SHAWYHGRIPRQVSE | 151 | O75815 | |
| ERNIPEVYVADGHWH | 4291 | Q6V0I7 | |
| EQVLHHIRYRNWRPA | 746 | Q9H4D0 | |
| WLYHHVEGFPERREA | 461 | O14641 | |
| HGSVRYWVKAELHRP | 131 | Q96B67 | |
| PRELWHLVHQCYGSE | 206 | Q96CP6 | |
| EEHWVHESGRPVQRA | 666 | P98160 | |
| RNWVDGVFHDPILRH | 436 | P78413 | |
| RITPHPGNEVRYHQW | 41 | Q8WWY6 | |
| PLWHHYLQAIRSREA | 16 | Q08AI8 | |
| YAKPQGRLHPHWESR | 456 | Q8TC57 | |
| VEYELLWGPRAHHET | 461 | Q8TD90 | |
| REWETRLQETLGPHY | 346 | Q9NRR6 | |
| GFEQEAHYPQWRRIH | 251 | Q96QG7 | |
| AHYPQWRRIHKSIER | 256 | Q96QG7 | |
| RRPSLVHGYPVLAWH | 31 | P14324 | |
| DHINLHVRGGYILPW | 2601 | O43451 | |
| YHGRWHGEVAIRLID | 681 | Q6VAB6 | |
| LVAEHLPGRQEHVFW | 1346 | O60318 | |
| VSHPRRIAVHYFKGW | 331 | Q9H252 | |
| FPGTWYLERVDEQHR | 486 | P54868 | |
| GHDGHPEYQIRWLIL | 31 | Q14999 | |
| RLWHNQIAYVPEHVR | 636 | Q6NSJ5 | |
| WVFAITRHHNRVPRE | 111 | Q9BR09 | |
| SSLRRHHELWPGVPY | 206 | Q9NUJ7 | |
| YWNVTLIPEGARHIR | 216 | Q6ZMM2 | |
| HQAGDHWLIRGPLEY | 351 | Q14764 | |
| LVAYWRREPGAEEHV | 166 | Q6UXL0 | |
| QGYRWCLHVVRIHPE | 381 | O95248 | |
| KNGRHPVVFRWHDIA | 246 | Q16825 | |
| RREELNGYIWHLIHA | 1446 | O00750 | |
| GQYVEVLDAAHPLRW | 5626 | Q5VST9 | |
| GRAHRDWYHRIDPTV | 31 | Q8WUK0 | |
| HRDTWGLSDEHFQPR | 341 | O75718 | |
| PTWAQQIREGRHHFL | 101 | Q49AR2 | |
| HARRVGLVEWHPTAA | 131 | Q92828 | |
| MSLEPWVAYRQHRGH | 111 | P15538 | |
| GHDGHPEYLIRWSVL | 31 | Q8IWT3 | |
| RLLQIWREQGYEHLH | 51 | P19099 | |
| RKRRSYNVHHPWETG | 71 | Q9NW75 | |
| PHEGRVEVYHDRRWG | 401 | Q6ZMJ2 | |
| TWRRTDVHLENPEYH | 81 | Q5VVW2 | |
| HNILSGQRWIEHYGE | 691 | Q9H4L5 | |
| SRQIRQFHFHGWPEV | 686 | P18433 | |
| DPNYWIQVHRLEHGD | 41 | Q8TEW0 | |
| WELHALRRHYHPIVQ | 691 | Q8WTT2 | |
| HEQLWYHGAIPRAEV | 456 | P07332 | |
| SWVRPHVRVYDNFGH | 726 | Q9NZ71 | |
| HRYHRHRPIEWAAEE | 121 | P0CI25 | |
| VRGRHYPWGVLQVEN | 261 | Q6ZU15 | |
| GHLRATVRWDYQPDI | 181 | Q8IZP6 | |
| IPVRGHHYWEVEVDE | 616 | A1L4K1 | |
| VIYINETHTRHRGWL | 91 | Q9HCL2 | |
| LYGPDNHLVEWHRTP | 216 | Q6STE5 | |
| HTHIQPWYLRVERAI | 356 | Q9H7Z7 | |
| QPIWGLHHLEYRAQD | 596 | P48029 | |
| RVWLPTAGFDHHVVR | 366 | Q9UBF8 | |
| LTWREFHYIQVHGRI | 226 | Q6NZ63 | |
| ARPHEAVGVHPYRAW | 216 | A6NFN9 | |
| RHRQIVSWFADHPRA | 211 | Q86TL0 | |
| VHVRQWDCRSLHYPV | 461 | Q8N2E2 | |
| HWRVHTGERPYECSE | 421 | P52740 | |
| DVRRVYLGEAHGPWV | 56 | Q96CK0 | |
| KGESWHDRYIHVRFP | 211 | Q96KV7 | |
| HLIVHQRTIWERPYE | 531 | Q9HCZ1 | |
| PERIHQRWQFHSIGL | 96 | Q6GYQ0 | |
| EEYRRQGLPNHHWRI | 171 | Q13496 | |
| RDHLVGRWIRTQQHY | 61 | P11217 | |
| DHECLGRWNTYIPLH | 286 | O95210 | |
| LLHTEHIWYPRIREI | 201 | Q9UGH3 | |
| SHIWHPRIREVQGAI | 146 | Q9UHI7 | |
| RRAVGHEPEHWSVYR | 601 | Q9Y5W7 | |
| HWAYRDGHLVNLPVS | 166 | Q12767 | |
| HRYHRHRPIEWAAEE | 121 | P0CI26 | |
| RDHLVGRWIRTQQHY | 61 | P11216 | |
| EHYRRWEPGSVRHST | 656 | Q96N46 | |
| LHCQWDQPVRYHRGD | 421 | Q96AE7 | |
| YHGHPQWLQEERVPR | 126 | Q96JE7 | |
| EWQHLGPVERTLYRD | 21 | Q5TYW1 | |
| LINHWRVHTGERPYE | 346 | Q6PK81 | |
| NLARHWRVHTGEKPY | 306 | Q09FC8 | |
| LIKHWRNHTGERPYE | 436 | Q8NEK5 | |
| RSHAWYHGRIPREVS | 216 | Q8N5H7 | |
| RAWDYPHGLVGLHNI | 46 | Q9UMW8 | |
| LIEHWRIHTGARPYE | 406 | Q9HCX3 | |
| WDPYTGERLRSLHHT | 266 | Q9NYS7 | |
| RYHIEVNRVPAGNWV | 536 | Q15029 | |
| RDHLVGRWIRTQQHY | 61 | P06737 | |
| WEHAGVRLPTHGRVY | 356 | Q13308 | |
| ILNRHWRIHTGEKPY | 251 | Q2M3W8 | |
| IDYRLRLHEWICHPD | 4811 | P20929 |